Restructuring lurks in pharmaceutical sector
Published: 2012-01-10 06:59:00
Updated: 2012-01-10 06:59:00
Korea’s pharmaceutical sector is poised to head for a fresh round of restructuring, with many drug makers pushing employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook due to the massive drug price cuts starting April.
The measure, designed to re...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
